References
- Aarnoutse, R. E., Kibiki, G. S., Reither, K., Semvua, H. H., Haraka, F., Mtabho, C. M., Mpagama, S. G., van den Boogaard, J., Sumari-de Boer, I. M., Magis-Escurra, C., Wattenberg, M., Logger, J. G. M., Te Brake, L. H. M., Hoelscher, M., Gillespie, S. H., Colbers, A., Phillips, P. P. J., Plemper van Balen, G., & Boeree, M. J. (2017). Pharmacokinetics, tolerability, and bacteriological response of rifampin administered at 600, 900, and 1,200 milligrams daily in patients with pulmonary tuberculosis. Antimicrobial Agents and Chemotherapy, 61(11), e01054. https://doi.org/https://doi.org/10.1128/AAC.01054-17
- Abraham, M. J., Murtola, T., Schulz, R., Pall, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Bhargava, A., Chatterjee, M., Jain, Y., Chatterjee, B., Kataria, A., Bhargava, M., Kataria, R., D’Souza, R., Jain, R., Benedetti, A., Pai, M., & Menzies, D. (2013). Nutritional status of adult patients with pulmonary tuberculosis in rural Central India and its association with mortality. PLoS One, 8(10), e77979. https://doi.org/https://doi.org/10.1371/journal.pone.0077979
- Borana, M. S., Mishra, P., Pissurlenkar, R. R. S., Hosur, R. V., & Ahmad, B. (2014). Curcumin and kaempferol prevent lysozyme fibril formation by modulating aggregation kinetic parameters. Biochimica et Biophysica Acta, 1844(3), 670–680. https://doi.org/https://doi.org/10.1016/j.bbapap.2014.01.009
- Borgdorff, M. W., & van Soolingen, D. (2013). The re-emergence of tuberculosis: What have we learnt from molecular epidemiology? Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 19(10), 889–901. https://doi.org/https://doi.org/10.1111/1469-0691.12253
- Cegielski, J. P., & McMurray, D. N. (2004). The relationship between malnutrition and tuberculosis: Evidence from studies in humans and experimental animals. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 8(3), 286–298.
- Chavan, R., Mukherjee, S., Dahake, R., Colvin, D., Kale, A., & Chowdhary, A. (2016). Differential proteomic analysis of respiratory samples from patients suffering from influenza. Virusdisease, 27(3), 226–233. https://doi.org/https://doi.org/10.1007/s13337-016-0332-x
- Clarke, M. (2010). Muscle sliding filaments. Nature Reviews Molecular Cell Biology, 9(S1), s7. https://doi.org/https://doi.org/10.1038/nrm2581
- Clarke, M., Kittendorf, J. D., Sgraja, T., Reuter, K., Klebe, G., Garcia, G. A., Huxley, H. E., Hanson, J., Crick, F., Watson, J., Spudich, J., Graham, J. A., Hynes, T. R., Block, S. M., White, B. T., Spudich, J. A., Hootman, J. M., Watson, K. B., Harris, C., … Jacobs, W. R. (2017). Combination therapy for tuberculosis treatment: Pulmonary administration of ethionamide and booster co-loaded nanoparticles. Nature Reviews Molecular Cell Biology, 8(2), 1641–1645.
- Cooper, G. M. 2000. The Cell: A Molecular Approach. 2ndedition. Sunderland, MA: Sinauer Associates. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK9839/
- Crick, F., & Watson, J. (1953). Adenosine triphosphate creatine transphophorylase as relaxing factor of muscle. Nature, 172(4391), 1181–1183.
- Debreczeni, J. É., & Emsley, P. (2012). Handling ligands with coot. Acta Crystallographica. Section D, Biological Crystallography, 68(Pt 4), 425–430. https://doi.org/https://doi.org/10.1107/S0907444912000200
- Denti, P., Castel, S., Wiesner, L., McIlleron, H., Martinson, N., Cohn, S., Hoffmann, J., Chaisson, R. E., Dooley, K. E., Mashabela, F., & Msandiwa, R. (2015). Population pharmacokinetics of rifampin in pregnant women with tuberculosis and HIV coinfection in Soweto, South Africa. Antimicrobial Agents and Chemotherapy, 60(3), 1234–1241. https://doi.org/https://doi.org/10.1128/AAC.02051-15
- Diallo, T., Adjobimey, M., Ruslami, R., Trajman, A., Sow, O., Obeng Baah, J., Marks, G. B., Long, R., Elwood, K., Zielinski, D., Gninafon, M., Wulandari, D. A., Apriani, L., Valiquette, C., Fregonese, F., Hornby, K., Li, P.-Z., Hill, P. C., Schwartzman, K., … Menzies, D. (2018). Safety and side effects of rifampin versus isoniazid in children. New England Journal of Medicine, 379(5), 454–463. https://doi.org/https://doi.org/10.1056/NEJMoa1714284
- Dodd, P. J., Yuen, C. M., Sismanidis, C., Seddon, J. A., & Jenkins, H. E. (2017). The global burden of tuberculosis mortality in children: A mathematical modelling study. The Lancet. Global Health, 5(9), e898–e906. https://doi.org/https://doi.org/10.1016/S2214-109X(17)30289-9
- Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010). Features and development of coot. Acta Crystallographica Section D: Biological Crystallography, 66(Pt 4), 486–501. https://doi.org/https://doi.org/10.1107/S0907444910007493
- Erhabor, G. E., Adewole, O. O., & Ogunlade, O. (2006). A five-year review of tuberculosis mortality amongst hospitalised patients in ile-ife. The Indian Journal of Chest Diseases & Allied Sciences, 48(4), 253–256.
- Galkin, V. E., Orlova, A., Kudryashov, D. S., Solodukhin, A., Reisler, E., Schröder, G. F., & Egelman, E. H. (2011). Remodeling of actin filaments by ADF/cofilin proteins. Proceedings of the National Academy of Sciences of the United States of America, 108(51), 20568–20572. https://doi.org/https://doi.org/10.1073/pnas.1110109108
- Gamble, J. (1992). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases (9th ed., Vol. 39). In B. Mandell (Ed.). Elsevier.
- Gautel, M., & Djinović-Carugo, K. (2016). The sarcomeric cytoskeleton: From molecules to motion. The Journal of Experimental Biology, 219(Pt 2), 135–145. https://doi.org/https://doi.org/10.1242/jeb.124941
- Geografi, J. K. N. (2019). Treatment of active pulmonary tuberculosis in adults: Current standards and recent advances. Αγαη, 8(5), 55.
- Glynn, J. R. (2007). The impact of HIV infection on tuberculosis in Africa. In HIV, resurgent infections and population change in Africa (pp. 215–228). Springer.
- Goody, R. S. (2003). The missing link in the muscle cross-bridge cycle. Nature Structural Biology, 10(10), 773–775. https://doi.org/https://doi.org/10.1038/nsb1003-773
- Gourlay, C. W., Carpp, L. N., Timpson, P., Winder, S. J., & Ayscough, K. R. (2004). A role for the actin cytoskeleton in cell death and aging in yeast. The Journal of Cell Biology, 164(6), 803–809. https://doi.org/https://doi.org/10.1083/jcb.200310148
- Graham, B. (1969). Comparative aspects of muscle. American Zoologist, 31(1), 43–82.
- Gupta, K. B., Gupta, R., Atreja, A., Verma, M., & Vishvkarma, S. (2009). Tuberculosis and nutrition. Lung India: Official Organ of Indian Chest Society, 26(1), 9–16. https://doi.org/https://doi.org/10.4103/0970-2113.45198
- Henderson, C. A., Gomez, C. G., Novak, S. M., Mi-Mi, L., & Gregorio, C. C. (2017). Overview of the muscle cytoskeleton. Comprehensive Physiology, 7(3), 891–944. https://doi.org/https://doi.org/10.1002/cphy.c160033
- Huxley, H. E., & Hanson, J. (1954). Changes in the crosss-striations of muscle during contraction and stretch and their structural interpretation. Nature, 173(4412), 973–976. https://doi.org/https://doi.org/10.1038/173973a0
- Hynes, T. R., Block, S. M., White, B. T., & Spudich, J. A. (1987). Movement of myosin fragments in vitro: Domains involved in force production. Cell, 48(6), 953–963. https://doi.org/https://doi.org/10.1016/0092-8674(87)90704-5
- Iseman, M. D. (2002). Tuberculosis therapy: Past, present and future. European Respiratory Journal, 20(Supplement 36), 87S–94S. https://doi.org/https://doi.org/10.1183/09031936.02.00309102
- Kerantzas, C. A., & Jacobs, W. R. (2017). Origins of combination therapy for tuberculosis: Lessons for future antimicrobial development and application. mBio, 8(2), 1–10. https://doi.org/https://doi.org/10.1128/mBio.01586-16
- Khan, A., Sterling, T. R., Reves, R., Vernon, A., Horsburgh, C. R., & Tuberculosis Trials Consortium. (2006). Lack of weight gain and relapse risk in a large tuberculosis treatment trial. American Journal of Respiratory and Critical Care Medicine, 174(3), 344–348. https://doi.org/https://doi.org/10.1164/rccm.200511-1834OC
- Liu, L. K., Abdelwahab, H., Martin Del Campo, J. S., Mehra-Chaudhary, R., Sobrado, P., & Tanner, J. J. (2016). The structure of the antibiotic deactivating, N-hydroxylating rifampicin monooxygenase. The Journal of Biological Chemistry, 291(41), 21553–21562. https://doi.org/https://doi.org/10.1074/jbc.M116.745315
- Liu, H., Pierre-Pierre, N., & Huo, Q. (2012). Dynamic light scattering for gold nanorod size characterization and study of nanorod-protein interactions. Gold Bulletin, 45(4), 187–195. https://doi.org/https://doi.org/10.1007/s13404-012-0067-4
- Lodish, H., Berk, A., Zipursky, S. L., Matsudaira, P.., Baltimore, D., and Darnell, J. 2000. Molecular Cell Biology, 4th ed. New York: W. H. Freeman. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK21475/
- Namisato, M., & Ogawa, H. (2000). Serious side effects of rifampin on the course of WHO/MDT: A case report. International Journal of Leprosy and Other Mycobacterial Diseases: Official Organ of the International Leprosy Association, 68(3), 277–282. https://doi.org/https://doi.org/10.1489/1544-581X(2004)72<468:AMACIT>2.0.CO;2
- Oshikoya, K. A., Sammons, H. M., & Choonara, I. (2010). A systematic review of pharmacokinetics studies in children with protein-energy malnutrition. European Journal of Clinical Pharmacology, 66(10), 1025–1035. https://doi.org/https://doi.org/10.1007/s00228-010-0851-0
- Oshikoya, K. A., & Senbanjo, I. O. (2009). Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutrition & Metabolism, 6(1), 50. https://doi.org/https://doi.org/10.1186/1743-7075-6-50
- Oshikoya, K. A., & Senbanjo, I. O. (2018). Caution when treating tuberculosis in malnourished children. Archives of Disease in Childhood, 103(12), 1101–1103. https://doi.org/https://doi.org/10.1136/archdischild-2018-314972
- Otterbein, L. R., Graceffa, P., & Dominguez, R. (2001). The crystal structure of uncomplexed actin in the ADP state. Science (Science), 293(5530), 708–711. https://doi.org/https://doi.org/10.1126/science.1059700
- Pantaloni, D., Carlier, M. F., Coué, M., Lal, A. A., Brenner, S. L., & Korn, E. D. (1984). The critical concentration of actin in the presence of ATP increases with the number concentration of filaments and approaches the critical concentration of actin ADP. The Journal of Biological Chemistry, 259(10), 6274–6283.
- Pathak, S., Tripathi, S., Deori, N., Ahmad, B., Verma, H., Lokhande, R., Nagotu, S., & Kale, A. (2020). Effect of tetracycline family of antibiotics on actin aggregation, resulting in the formation of hirano bodies responsible for neuropathological disorders. Journal of Biomolecular Structure and Dynamics, 1–18.
- Sawaya, M. R., Kudryashov, D. S., Pashkov, I., Adisetiyo, H., Reisler, E., & Yeates, T. O. (2008). Multiple crystal structures of actin dimers and their implications for interactions in the actin filament. Acta Crystallographica. Section D, Biological Crystallography, 64(Pt 4), 454–465. https://doi.org/https://doi.org/10.1107/S0907444908003351
- Schaberg, T., Rebhan, K., & Lode, H. (1996). Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. The European Respiratory Journal, 9(10), 2026–2030. https://doi.org/https://doi.org/10.1183/09031936.96.09102026
- Seijger, C., Hoefsloot, W., Bergsma De Guchteneire, I., Te Brake, L., Van Ingen, J., Kuipers, S., Van Crevel, R., Aarnoutse, R., Boeree, M., & Magis-Escurra, C. (2019). High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre. PLoS One, 14(3), e0213718. https://doi.org/https://doi.org/10.1183/13993003.congress-2019.OA2132
- Shimizu, N., & Obinata, T. (1986). Actin concentration and monomer-polymer ratio in developing chicken skeletal muscle. Journal of Biochemistry, 99(3), 751–759. https://doi.org/https://doi.org/10.1093/oxfordjournals.jbchem.a135534
- Skwarek-Maruszewska, A., Hotulainen, P., Mattila, P. K., & Lappalainen, P. (2009). Contractility-dependent actin dynamics in cardiomyocyte sarcomeres. Journal of Cell Science, 122(Pt 12), 2119–2126. https://doi.org/https://doi.org/10.1242/jcs.046805
- Solomon, E. I., Augustine, A. J., & Yoon, J. (2010). Rapid and efficient purification of actin from nonmuscle sources. Cell Motility and the Cytoskeleton, 39(30), 3921–3932.
- Svensson, E. M., Svensson, R. J., Te Brake, L. H. M., Boeree, M. J., Heinrich, N., Konsten, S., Churchyard, G., Dawson, R., Diacon, A. H., Kibiki, G. S., Minja, L. T., Ntingiya, N. E., Sanne, I., Gillespie, S. H., Hoelscher, M., Phillips, P. P. J., Simonsson, U. S. H., & Aarnoutse, R. (2018). The potential for treatment shortening with higher rifampicin doses: Relating drug exposure to treatment response in patients with pulmonary tuberculosis. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 67(1), 34–41. https://doi.org/https://doi.org/10.1093/cid/ciy026
- Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
- Van Crevel, R., Verhoef, H., Nelwan, R. H. H., Van Der Meer, J. W. M., Karyadi, E., Netea, M. G., & West, C. E. (2002). Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. The Journal of Clinical Endocrinology & Metabolism, 87(2), 758–763. https://doi.org/https://doi.org/10.1210/jcem.87.2.8228
- Warmelink, I., Ten Hacken, N. H., Van Der Werf, T. S., & Van Altena, R. (2011). Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. The British Journal of Nutrition, 105(3), 400–408. https://doi.org/https://doi.org/10.1017/S0007114510003636
- WHO. (2018). Cascade data use manual to identify gaps in HIV and Health services for programme improvement HIV strategic information for impact user manual. WHO.
- World Health Organisation. (2018). Global health TB report. WHO.